0.9% w/v sodium chloride solution for intravenous infusion, Panzyga 100 mg/ml Infusionslösung clinical trials

A superiority phase III study to compare the effect of Panzyga versus placebo in patients with pediatric acute-onset neuropsychiatric syndrome

This study is testing a medicine called Panzyga for children with PANS, a condition causing sudden changes in their brain and behaviour. We want to see if Panzyga helps improve their symptoms better than a dummy treatment.